HIA
MRNA icon

Harbor Investment Advisory’s Moderna MRNA Stock Holding History

Harbor Investment Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-600
Closed -$16.6K – 1205
2025
Q2 		$16.6K Sell
600
-218
-27% -$5.74K ﹤0.01% 806
2025
Q1 		$23.2K Buy
818
+18
+2% +$639 ﹤0.01% 753
2024
Q4 		$33.3K Sell
800
-1,843
-70% -$88.1K ﹤0.01% 666
2024
Q3 		$177K Sell
2,643
-3,505
-57% -$322K 0.02% 360
2024
Q2 		$730K Sell
6,148
-570
-8% -$72.1K 0.08% 184
2024
Q1 		$716K Sell
6,718
-795
-11% -$80.1K 0.07% 192
2023
Q4 		$747K Sell
7,513
-1,118
-13% -$94K 0.09% 176
2023
Q3 		$891K Buy
8,631
+1,208
+16% +$135K 0.12% 148
2023
Q2 		$902K Sell
7,423
-120
-2% -$16K 0.13% 147
2023
Q1 		$1.16M Sell
7,543
-1,681
-18% -$277K 0.17% 116
2022
Q4 		$1.66M Sell
9,224
-381
-4% -$62.3K 0.26% 83
2022
Q3 		$1.14M Sell
9,605
-1,091
-10% -$166K 0.19% 103
2022
Q2 		$1.53M Sell
10,696
-515
-5% -$73.6K 0.24% 88
2022
Q1 		$1.93M Sell
11,211
-1,587
-12% -$267K 0.26% 80
2021
Q4 		$3.25M Sell
12,798
-226
-2% -$66.1K 0.41% 48
2021
Q3 		$5.01M Sell
13,024
-639
-5% -$236K 0.68% 28
2021
Q2 		$3.21M Sell
13,663
-415
-3% -$74.2K 0.43% 45
2021
Q1 		$1.84M Buy
14,078
+5,115
+57% +$741K 0.28% 74
2020
Q4 		$936K Buy
8,963
+4,043
+82% +$409K 0.15% 117
2020
Q3 		$348K Buy
4,920
+3,850
+360% +$268K 0.07% 203
2020
Q2 		$69K Buy
1,070
+970
+970% +$53.1K 0.01% 400
2020
Q1 		$3K Buy
+100
New +$2.3K ﹤0.01% 904

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Harbor Investment Advisory's MRNA Position: Q3 2025 in Review

Harbor Investment Advisory sold out of Moderna (MRNA) in Q3 2025, closing a stake of 600 shares — an estimated $16.6K sold.

Harbor Investment Advisory first reported a position in MRNA in Q1 2020 and held it in 22 quarters. The position peaked at $5.01M in Q3 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Harbor Investment Advisory reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Harbor Investment Advisory sold 600 Moderna shares in Q3 2025, an estimated $16.6K.
  • Harbor Investment Advisory first reported a position in Moderna in Q1 2020 and held it in 22 quarters.
  • Harbor Investment Advisory's Moderna position peaked at $5.01M in Q3 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Harbor Investment Advisory's 13F filing for Q3 2025, filed 27 Oct 2025.